Rating History for Jazz Pharmaceuticals (JAZZ) by UBS

More Stocks Rated by UBS | Latest Ratings for JAZZ
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/19/2026 Ashwani Verma Upgrade Buy
(Neutral)		 307.00
(188.00)		 228.77
(243.47)		 6.43% Details